X0206 3 2023-06-01 0 0001601485 Elicio Therapeutics, Inc. ELTX 0001796436 Connelly Robert C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR, SUITE 501 BOSTON MA 02210 true true CEO, President and Director Common Stock 46970 D Stock Option (right to buy) 9.39 2030-09-08 Common Stock 27150 D Stock Option (right to buy) 3.87 2032-11-28 Common Stock 147913 D Shares of capital stock of the corporation then known as Elicio Therapeutics, Inc. ("Old Elicio") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of January 17, 2023, by and among the Issuer, Arkham Merger Sub, Inc. and Old Elicio (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of capital stock was exchanged for 0.0181 shares of the Issuer's common stock, giving effect to a reverse split of the Issuer's common stock of 10-to-1. Represents 27,150 stock options granted under the Issuer's 2012 Equity Incentive Plan. The stock options vested in full on January 31, 2021. Represents 147,913 stock options granted under the Issuer's 2012 Equity Incentive Plan. The options vest in equal monthly installments over three years, beginning of November 28, 2022. Exhibit 24.1 - Power of Attorney. /s/ Nishant M. Dharia, Attorney-in-fact 2023-06-07